Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00241514 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: Esomeprazole

Sponsor

AstraZeneca